疼痛管理の世界市場 (2023-2030年)：用途 (神経障害性疼痛・癌性疼痛)・流通チャネル (オンライン薬局・小売薬局) 別の規模・シェア・成長分析・予測

世界の疼痛管理の市場規模は、2021年の721億米ドル、予測期間中は4.3%のCAGRで推移し、2022年の752億米ドルから、2030年には1,053億2,000万米ドルの規模に成長すると予測されています。

世界の疼痛管理市場は、関節炎、癌性疼痛、神経障害性疼痛、筋骨格系障害などの慢性疼痛疾患の有病率の上昇により、大幅に拡大しています。このような慢性疼痛患者の急増が、効果的な疼痛緩和ソリューションの需要を押し上げています。新規医薬品、医療機器、低侵襲手術などの疼痛管理技術の進歩に加え、神経調節や標的薬物送達システムなどの先端技術の統合によっても、効果的な治療の選択肢の幅が広がっています。

しかし、オピオイドの乱用や中毒に対する懸念などの課題も存在し、規制の強化や疼痛管理におけるオピオイド以外の代替薬へのシフトが促されています。そのため、ヘルスケアプロバイダーや製薬企業は、疼痛緩和のニーズと潜在的リスクのバランスを取るという課題を抱えています。

当レポートでは、世界の疼痛管理の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。

目次

• エグゼクティブサマリー
• 調査手法
• 親市場の分析
  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
• 主要な市場洞察
  • 技術分析
  • 価格分析
  • サプライチェーン分析
  • バリューチェーン分析
  • 市場のエコシステム
  • IP分析
  • 貿易分析
  • スタートアップ分析
  • 原材料分析
  • イノベーションマトリックス
  • パイプライン製品の分析
  • マクロ経済指標
  • 主要投資分析
  • 主要な成功要因
  • 競合の程度
  • 市場力学と見通し
    • 市場力学
      • 促進要因
      • 機会
      • 抑制要因
      • 課題
  • 規制状況
  • ポーターの分析
  • 将来のディスラプションに関するSkyquestの特別な洞察
• 世界の疼痛管理市場：用途別
  • 市場概要
  • 神経因性疼痛
  • 癌性疼痛
  • 顔面疼痛・片頭痛
  • 筋骨格疼痛
  • その他
• 世界の疼痛管理市場：流通チャネル別
  • 市場概要
  • オンライン薬局
  • 小売薬局
  • 病院薬局
• 世界の疼痛管理市場：地域別
  • 市場概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• 競合情勢
  • トップ5社の比較
  • 主要企業の市場での位置付け
  • 主要企業の採用戦略
  • 主要成功戦略
  • 市場における最近の活動
  • 主要企業の市場シェア
• 主要企業プロファイル
  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis International AG
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • AbbVie Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Bristol Myers Squibb Company
  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • St. Jude Medical, Inc.
  • Stryker Corporation
  • Cardinal Health, Inc.
  • Halyard Health (O&M Halyard)
  • Mallinckrodt Pharmaceuticals

Global Pain Management Market size was valued at USD 72.1 Billion in 2021 and is poised to grow from USD 75.20 Billion in 2022 to USD 105.32 Billion by 2030, at a CAGR of 4.3% during the forecast period (2023-2030).

The global pain management market has experienced substantial expansion due to the rising prevalence of chronic pain conditions, including arthritis, cancer pain, neuropathic pain, and musculoskeletal disorders. This surge in chronic pain cases has driven demand for effective pain relief solutions. Advancements in pain management technologies, such as novel pharmaceuticals, medical devices, and minimally invasive procedures, along with the integration of advanced technologies like neuromodulation and targeted drug delivery systems, have broadened the range of effective treatment options. However, challenges exist, including concerns about opioid abuse and addiction, which have prompted stricter regulations and a shift toward non-opioid alternatives for pain management, thereby presenting healthcare providers and pharmaceutical companies with the task of balancing pain relief needs with potential risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pain management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global pain management market is segmented on the basis of application, distribution channel, and region. By application, the market is segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and other applications. By distribution channel, the market is segmented into online pharmacy, retail pharmacy, and hospital pharmacy. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Increasing Awareness and Focus on Pain Management

A heightened understanding of pain's profound influence on people's well-being is prompting healthcare providers, patients, and policymakers to prioritize pain management, resulting in intensified research, education, and enhanced access to efficient pain relief. This emphasis on patient-centered care and better pain management outcomes is propelling the market forward.

Rising Geriatric Population

The pain management market is being notably influenced by the aging population, given that older adults are at a higher risk of experiencing chronic pain issues like osteoarthritis and neuropathic pain. As the world experiences a growing trend of aging demographics, the need for pain management solutions is on the rise, as elderly individuals actively seek efficient ways to alleviate pain and sustain their overall well-being and autonomy.

Restraints:

High Cost of Pain Management Treatments

The growth of the market for pain management treatments can be impeded by the high costs associated with advanced procedures and devices, which may hinder access for specific patient groups, especially in low-income regions or countries with limited healthcare resources. The expenses related to medications, surgical interventions, and specialized therapies pose a significant barrier to broader market expansion.

Regulatory and Reimbursement Challenges

The pain management industry is influenced by regulatory stipulations and reimbursement obstacles that can impede its expansion. Regulatory factors, such as constraints on opioid prescription and medical device regulations, play a pivotal role in shaping the accessibility of pain management solutions. Additionally, reimbursement policies and constraints can impact the adoption and utilization of specific pain management treatments.

Market Trends:

The current trend in pain management involves a growing focus on multimodal, personalized approaches that encompass a range of therapies and interventions to address pain comprehensively. This includes a combination of pharmaceutical treatments, non-pharmacological therapies, physical therapy, psychological interventions, and lifestyle modifications, all tailored to the specific needs of each patient, considering factors like the pain's underlying cause, comorbidities, and patient preferences. Additionally, minimally invasive procedures for pain relief, such as nerve blocks, radiofrequency ablation, and spinal cord stimulation, are becoming increasingly popular due to their targeted pain relief, reduced invasiveness, shorter recovery periods, and potential for fewer side effects when compared to traditional surgical methods, driven by advancements in medical technology and healthcare professionals' growing expertise.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Pain Management Market by Application
  • Market Overview
  • Neuropathic pain
  • cancer pain
  • facial pain and migraine
  • musculoskeletal pain
  • and other applications
• Global Pain Management Market by Distribution Channel
  • Market Overview
  • Online pharmacy
  • retail pharmacy
  • and hospital pharmacy
• Global Pain Management Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • Johnson & Johnson - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pfizer Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Novartis International AG - Switzerland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Eli Lilly and Company - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • GlaxoSmithKline PLC - United Kingdom
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • AbbVie Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • AstraZeneca PLC - United Kingdom
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bayer AG - Germany
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Merck & Co., Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Teva Pharmaceutical Industries Ltd. - Israel
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sanofi S.A. - France
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bristol Myers Squibb Company - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medtronic PLC - Ireland
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Abbott Laboratories - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Boston Scientific Corporation - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • St. Jude Medical, Inc. (Abbott) - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Stryker Corporation - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Cardinal Health, Inc. - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Halyard Health (O&M Halyard) - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Mallinckrodt Pharmaceuticals - US
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments